Further studies on the interaction of nonpolyglutamatable aminopterin analogs with dihydrofolate reductase and the reduced folate carrier as determinants of in vitro antitumor activity.
Further studies on the interaction of nonpolyglutamatable aminopterin analogs with dihydrofolate reductase and the reduced folate carrier as determinants of in vitro antitumor activity.
复制标题
进一步研究非聚谷氨酸氨基蝶呤类似物与二氢叶酸还原酶和还原叶酸载体的相互作用作为体外抗肿瘤活性的决定因素。
DOI:
10.1016/s0006-2952(03)00102-3
复制
发表时间:
2003
影响因子:
5.8
通讯作者:
Rosowsky,Andre
中科院分区:
文献类型:
--
作者:
Wright,JoelE;Yurasek,GregoryK;Chen,Ying-Nan;Rosowsky,Andre
Thirteen structural analogs of the potent nonpolyglutamatable dihydrofolate reductase inhibitor Nα-(4-amino-4-deoxypteroyl)-Nδ-hemiphthaloyl-l-ornithine (PT523) with modifications in the side chain, the para-aminobenzoyl moiety, or the 9,10-bridge were evaluated for the ability to inhibit human recombinant dihydrofolate reductase (DHFR), to utilize the reduced folate carrier (RFC) for influx, and to inhibit the growth of CCRF-CEM human leukemia cells in culture. In spectrophotometric assays of the kinetics of the reduction of dihydrofolate by DHFR in the presence of NADPH, these compounds had Kivalues ranging from 0.2 to 1.3pM, and thus were not greatly different in potency from the parent drug PT523. By comparison, the Kivalues of aminopterin (AMT), methotrexate (MTX), and 10-ethyl-10-deazaaminopterin (EDX) were 3.7, 4.8, and 11pM. In assays of competitive inhibition of [3H ]MTX influx into CCRF-CEM cells, the Kivalues ranged from 0.21 to 7.3μM, as compared with 0.71, 5.4, and 1.1μM for PT523, AMT, and EDX. The Ktfor MTX was also re-analyzed and found to be 4.7μM, in better agreement with the literature than our previously reported value of 7.1μM. The ic50values of these compounds as inhibitors of the growth of CCRF-CEM cells after 72hr of drug exposure ranged from 0.53 to 55nM, and were qualitatively consistent with the other results.